Four things to know:
1. Dr. Murphy has more than 20 years of experience in the medical device industry, with executive leadership roles at Medtronic, LivaNova and St. Jude Medical.
2. He spent 10 years at Medtronic in several research and development and engineering roles. Most recently, he served as CTO of LivaNova, which specializes in neuromodulation and cardiac surgery systems.
3. Dr. Murphy will be tasked with advancing GTX’s neuromodulation line, which aims to improve the functional recovery of people with spinal cord injuries.
4. GTX develops implantable and non-invasive spinal cord stimulation devices.
More articles on devices:
$4.7M SBA loan given to Conformis to mitigate economic impact of COVID-19
Elective, outpatient surgery begin to return — insights for spine surgeons
$838M neuroscience facility at Connecticut hospital gains unanimous approval
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.